Nelson James Carl
CIK: 0002134292
Nelson James Carl's purchase track record
Nelson James Carl has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/15/2026 | EROK | $1.85M | +16.1% | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
this person other insiders at EROK
Transaction History
| EROK | ▲ Buy | Grant | 7,534 | $0 | 9/10/2026 | View on chart |
| EROK | ▲ Buy | Open Market | 50,000 | $925K | 5/15/2026 | View on chart |
| EROK | ▲ Buy | Open Market | 50,000 | $925K | 5/15/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
EagleRock Land valuation shows DCF far below market price
A recent analysis estimates EagleRock Land’s discounted cash flow value to be about 67% lower than its current share price. The gap suggests the market may be pricing the stock above its intrinsic estimate. The stock is trading near its 52‑week low and has an RSI around 40, indicating limited upward momentum. Investors may consider the valuation contrast when assessing the company.
EagleRock Land valuation shows DCF far below market price. A recent analysis estimates EagleRock Land’s discounted cash flow value to be about 67% lower than its current share price. The gap suggests the market may be pricing the stock above its intrinsic estimate. The stock is trading near its 52‑week low and has an RSI around 40, indicating limited upward momentum. Investors may consider the valuation contrast when assessing the company.